Pharma Stocks Remain Undervalued Despite Clinton Loss

The day Trump was elected as president, pharmaceutical stocks rallied, however, since then they have slumped back, as the future of the sector remains uncertain. Ketan Patel, fund manager at EdenTree talks to Morningstar about the future of Obamacare, stating that it is highly unlikely that Trump will abolish the Affordable Care Act, as it would lead to greater uncertainty in the short to medium term.

Link

top